These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11796337)

  • 1. In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci.
    Johnson AP; Warner M; Carter M; Livermore DM
    Antimicrob Agents Chemother; 2002 Feb; 46(2):321-6. PubMed ID: 11796337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
    Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
    Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases.
    Malouin F; Blais J; Chamberland S; Hoang M; Park C; Chan C; Mathias K; Hakem S; Dupree K; Liu E; Nguyen T; Dudley MN
    Antimicrob Agents Chemother; 2003 Feb; 47(2):658-64. PubMed ID: 12543674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of RWJ-54428 against Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecalis in a neutropenic mouse thigh infection model.
    Griffith DC; Rodriguez D; Corcoran E; Dudley MN
    Antimicrob Agents Chemother; 2008 Jan; 52(1):244-7. PubMed ID: 17954697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of a new cephalosporin, RWJ-54428, against streptococci, enterococci and staphylococci, including glycopeptide-intermediate Staphylococcus aureus.
    Swenson JM; Tenover FC
    J Antimicrob Chemother; 2002 May; 49(5):845-50. PubMed ID: 12003982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci.
    Sader HS; Johnson DM; Jones RN
    Antimicrob Agents Chemother; 2004 Jan; 48(1):53-62. PubMed ID: 14693518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic resistance of Gram-positive cocci isolated in 2008].
    Dorobăţ OM; Bădicuţ I; Tălăpan D; Tenea C; Rafila A
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(2):83-92. PubMed ID: 21553473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
    Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
    Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
    McGee L; Biek D; Ge Y; Klugman M; du Plessis M; Smith AM; Beall B; Whitney CG; Klugman KP
    Antimicrob Agents Chemother; 2009 Feb; 53(2):552-6. PubMed ID: 19015339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
    Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2383-8. PubMed ID: 18443115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria.
    Griffith DC; Harford L; Williams R; Lee VJ; Dudley MN
    Antimicrob Agents Chemother; 2003 Jan; 47(1):43-7. PubMed ID: 12499167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.
    Livermore DM; Warner M; Mushtaq S; North S; Woodford N
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1112-4. PubMed ID: 17210773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of teicoplanin against gram-positive cocci.
    Allouch P; Pina P; Chaplain C; Delarbre JM; Geffroy F; Grasmick CP; Marcolin M; Morel A; Pangon B; Rio Y; Sédaillan A
    Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of ceftobiprole against Gram-positive cocci.
    Betriu C; Culebras E; Gómez M; López-Fabal F; Rodríguez-Avial I; Picazo JJ
    Int J Antimicrob Agents; 2010 Aug; 36(2):111-3. PubMed ID: 20554163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
    Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.